| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |